Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 106

1.

The Fluctuations of Leukocytes and Circulating Cytokines in Septic Humanized Mice Vary With Outcome.

Skirecki T, Drechsler S, Hoser G, Jafarmadar M, Siennicka K, Pojda Z, Kawiak J, Osuchowski MF.

Front Immunol. 2019 Jun 26;10:1427. doi: 10.3389/fimmu.2019.01427. eCollection 2019.

2.

Mobilization of Stem and Progenitor Cells in Septic Shock Patients.

Skirecki T, Mikaszewska-Sokolewicz M, Godlewska M, Dołęgowska B, Czubak J, Hoser G, Kawiak J, Zielińska-Borkowska U.

Sci Rep. 2019 Mar 1;9(1):3289. doi: 10.1038/s41598-019-39772-4.

3.

Response of human normal and leukemia cells to factors released by amnion fragments in vitro.

Grzywocz Z, Hoser G, Sabalinska S, Ladyzynski P, Czubak J, Dworczynska M, Debski R, Pius-Sadowska E, Machalinski B, Kawiak J.

PLoS One. 2018 Mar 29;13(3):e0195035. doi: 10.1371/journal.pone.0195035. eCollection 2018.

4.

Expression of PIM kinases in Reed-Sternberg cells fosters immune privilege and tumor cell survival in Hodgkin lymphoma.

Szydłowski M, Prochorec-Sobieszek M, Szumera-Ciećkiewicz A, Derezińska E, Hoser G, Wasilewska D, Szymańska-Giemza O, Jabłońska E, Białopiotrowicz E, Sewastianik T, Polak A, Czardybon W, Gałęzowski M, Windak R, Zaucha JM, Warzocha K, Brzózka K, Juszczyński P.

Blood. 2017 Sep 21;130(12):1418-1429. doi: 10.1182/blood-2017-01-760702. Epub 2017 Jul 11.

PMID:
28698206
5.

Gene expression and mutation-guided synthetic lethality eradicates proliferating and quiescent leukemia cells.

Nieborowska-Skorska M, Sullivan K, Dasgupta Y, Podszywalow-Bartnicka P, Hoser G, Maifrede S, Martinez E, Di Marcantonio D, Bolton-Gillespie E, Cramer-Morales K, Lee J, Li M, Slupianek A, Gritsyuk D, Cerny-Reiterer S, Seferynska I, Stoklosa T, Bullinger L, Zhao H, Gorbunova V, Piwocka K, Valent P, Civin CI, Muschen M, Dick JE, Wang JC, Bhatia S, Bhatia R, Eppert K, Minden MD, Sykes SM, Skorski T.

J Clin Invest. 2017 Jun 1;127(6):2392-2406. doi: 10.1172/JCI90825. Epub 2017 May 8.

6.

Bacteriophage-Based Bioconjugates as a Flow Cytometry Probe for Fast Bacteria Detection.

Janczuk M, Richter Ł, Hoser G, Kawiak J, Łoś M, Niedziółka-Jönsson J, Paczesny J, Hołyst R.

Bioconjug Chem. 2017 Feb 15;28(2):419-425. doi: 10.1021/acs.bioconjchem.6b00596. Epub 2016 Dec 19.

PMID:
27990800
7.

PARP1 inhibitor olaparib (Lynparza) exerts synthetic lethal effect against ligase 4-deficient melanomas.

Czyż M, Toma M, Gajos-Michniewicz A, Majchrzak K, Hoser G, Szemraj J, Nieborowska-Skorska M, Cheng P, Gritsyuk D, Levesque M, Dummer R, Sliwinski T, Skorski T.

Oncotarget. 2016 Nov 15;7(46):75551-75560. doi: 10.18632/oncotarget.12270.

8.

Decreased Expression of SRSF2 Splicing Factor Inhibits Apoptotic Pathways in Renal Cancer.

Kędzierska H, Popławski P, Hoser G, Rybicka B, Rodzik K, Sokół E, Bogusławska J, Tański Z, Fogtman A, Koblowska M, Piekiełko-Witkowska A.

Int J Mol Sci. 2016 Sep 28;17(10). pii: E1598.

9.

The Early Expression of HLA-DR and CD64 Myeloid Markers Is Specifically Compartmentalized in the Blood and Lungs of Patients with Septic Shock.

Skirecki T, Mikaszewska-Sokolewicz M, Hoser G, Zielińska-Borkowska U.

Mediators Inflamm. 2016;2016:3074902. doi: 10.1155/2016/3074902. Epub 2016 Jun 19.

10.

Human endothelial cells hollow fiber membrane bioreactor as a model of the blood vessel for in vitro studies.

Ciechanowska A, Ladyzynski P, Hoser G, Sabalinska S, Kawiak J, Foltynski P, Wojciechowski C, Chwojnowski A.

J Artif Organs. 2016 Sep;19(3):270-7. doi: 10.1007/s10047-016-0902-0. Epub 2016 Apr 30.

PMID:
27139241
11.

Normal ABL1 is a tumor suppressor and therapeutic target in human and mouse leukemias expressing oncogenic ABL1 kinases.

Dasgupta Y, Koptyra M, Hoser G, Kantekure K, Roy D, Gornicka B, Nieborowska-Skorska M, Bolton-Gillespie E, Cerny-Reiterer S, Müschen M, Valent P, Wasik MA, Richardson C, Hantschel O, van der Kuip H, Stoklosa T, Skorski T.

Blood. 2016 Apr 28;127(17):2131-43. doi: 10.1182/blood-2015-11-681171. Epub 2016 Feb 10.

12.

Mitochondrial mutagenesis in BCR-ABL1-expressing cells sensitive and resistant to imatinib.

Blasiak J, Hoser G, Bialkowska-Warzecha J, Pawlowska E, Skorski T.

Acta Biochim Pol. 2016;63(2):365-70. doi: 10.18388/abp.2015_1189. Epub 2016 Jan 12.

13.

Synthetic Calcite as a Scaffold for Osteoinductive Bone Substitutes.

Chróścicka A, Jaegermann Z, Wychowański P, Ratajska A, Sadło J, Hoser G, Michałowski S, Lewandowska-Szumiel M.

Ann Biomed Eng. 2016 Jul;44(7):2145-57. doi: 10.1007/s10439-015-1520-3. Epub 2015 Dec 14.

14.

Doxorubicin Differentially Induces Apoptosis, Expression of Mitochondrial Apoptosis-Related Genes, and Mitochondrial Potential in BCR-ABL1-Expressing Cells Sensitive and Resistant to Imatinib.

Synowiec E, Hoser G, Bialkowska-Warzecha J, Pawlowska E, Skorski T, Blasiak J.

Biomed Res Int. 2015;2015:673512. doi: 10.1155/2015/673512. Epub 2015 Nov 4.

15.

Progression of inflammation during immunodeficient mouse skeletal muscle regeneration.

Grabowska I, Mazur MA, Kowalski K, Helinska A, Moraczewski J, Stremińska W, Hoser G, Kawiak J, Ciemerych MA, Brzoska E.

J Muscle Res Cell Motil. 2015 Dec;36(6):395-404. doi: 10.1007/s10974-015-9433-1. Epub 2015 Nov 27.

16.

Reactive Oxygen Species and Mitochondrial DNA Damage and Repair in BCR-ABL1 Cells Resistant to Imatinib.

Blasiak J, Hoser G, Bialkowska-Warzecha J, Pawlowska E, Skorski T.

Biores Open Access. 2015 Jul 1;4(1):334-42. doi: 10.1089/biores.2015.0022. eCollection 2015.

17.

Early severe impairment of hematopoietic stem and progenitor cells from the bone marrow caused by CLP sepsis and endotoxemia in a humanized mice model.

Skirecki T, Kawiak J, Machaj E, Pojda Z, Wasilewska D, Czubak J, Hoser G.

Stem Cell Res Ther. 2015 Aug 14;6:142. doi: 10.1186/s13287-015-0135-9.

18.

UV Differentially Induces Oxidative Stress, DNA Damage and Apoptosis in BCR-ABL1-Positive Cells Sensitive and Resistant to Imatinib.

Synowiec E, Hoser G, Wojcik K, Pawlowska E, Skorski T, Błasiak J.

Int J Mol Sci. 2015 Aug 5;16(8):18111-28. doi: 10.3390/ijms160818111.

19.

Human lymphocytic B-leukemia cell line treatment with the bacterial toxin listeriolysin O and rituximab (anti-CD20 antibody): Effects of similar localization of their receptors.

Gryzik M, Grzywocz Z, Wasilewska D, Kawiak J, Stachowiak R, Bielecki J, Hoser G.

Int J Immunopathol Pharmacol. 2015 Sep;28(3):329-40. doi: 10.1177/0394632015595778. Epub 2015 Jul 27.

PMID:
26216910
20.

Mechanisms of immune response regulation in lung cancer.

Domagala-Kulawik J, Osinska I, Hoser G.

Transl Lung Cancer Res. 2014 Feb;3(1):15-22. doi: 10.3978/j.issn.2218-6751.2013.11.03. Review.

21.

Selenitetriglycerides-Redox-active agents.

Flis A, Suchocki P, Królikowska MA, Suchocka Z, Remiszewska M, Śliwka L, Książek I, Sitarz K, Sochacka M, Hoser G, Anuszewska E, Wroczyński P, Jastrzębski Z.

Pharmacol Rep. 2015 Feb;67(1):1-8. doi: 10.1016/j.pharep.2014.07.017. Epub 2014 Aug 14.

PMID:
25560568
22.

Factors affecting decision concerning influenza vaccination among students of medical faculties.

Woźniak-Kosek A, Kempińska-Mirosławska B, Mendrycka M, Saracen A, Hoser G.

Acta Biochim Pol. 2014;61(4):829-32. Epub 2014 Dec 19.

23.

Growth factors and their receptors derived from human amniotic cells in vitro.

Grzywocz Z, Pius-Sadowska E, Klos P, Gryzik M, Wasilewska D, Aleksandrowicz B, Dworczynska M, Sabalinska S, Hoser G, Machalinski B, Kawiak J.

Folia Histochem Cytobiol. 2014;52(3):163-70. doi: 10.5603/FHC.2014.0019.

24.

Detection of the influenza virus yesterday and now.

Woźniak-Kosek A, Kempińska-Mirosławska B, Hoser G.

Acta Biochim Pol. 2014;61(3):465-70. Epub 2014 Sep 1. Review.

25.

Cytotoxicity of purified listeriolysin O on mouse and human leukocytes and leukaemia cells.

Stachowiak R, Łyżniak M, Grabowska M, Roeske K, Jagielski T, Bielecki J, Budziszewska BK, Hoser G, Kawiak J.

BMC Biotechnol. 2014 Aug 18;14:77. doi: 10.1186/1472-6750-14-77.

26.

Monitoring cell proliferation in vitro with different cellular fluorescent dyes.

Zolnierowicz J, Ambrozek-Latecka M, Kawiak J, Wasilewska D, Hoser G.

Folia Histochem Cytobiol. 2013;51(3):193-200. doi: 10.5603/FHC.2013.0027.

27.

Flow cytometric analysis of CD133- and EpCAM-positive cells in the peripheral blood of patients with lung cancer.

Skirecki T, Hoser G, Kawiak J, Dziedzic D, Domagała-Kulawik J.

Arch Immunol Ther Exp (Warsz). 2014 Feb;62(1):67-75.

28.

Anti-oxidant vitamin E prevents accumulation of imatinib-resistant BCR-ABL1 kinase mutations in CML-CP xenografts in NSG mice.

Nieborowska-Skorska M, Hoser G, Hochhaus A, Stoklosa T, Skorski T.

Leukemia. 2013 Nov;27(11):2253-4. doi: 10.1038/leu.2013.123. Epub 2013 Apr 22. No abstract available.

29.

Genomic instability may originate from imatinib-refractory chronic myeloid leukemia stem cells.

Bolton-Gillespie E, Schemionek M, Klein HU, Flis S, Hoser G, Lange T, Nieborowska-Skorska M, Maier J, Kerstiens L, Koptyra M, Müller MC, Modi H, Stoklosa T, Seferynska I, Bhatia R, Holyoake TL, Koschmieder S, Skorski T.

Blood. 2013 May 16;121(20):4175-83. doi: 10.1182/blood-2012-11-466938. Epub 2013 Mar 29.

30.

Diverse mechanisms of mTOR activation in chronic and blastic phase of chronic myelogenous leukemia.

Stoklosa T, Glodkowska-Mrowka E, Hoser G, Kielak M, Seferynska I, Wlodarski P.

Exp Hematol. 2013 May;41(5):462-9. doi: 10.1016/j.exphem.2013.02.001. Epub 2013 Feb 5.

PMID:
23395818
31.

Effect of granulocyte colony-stimulating factor on circulating immune and stem cells in septic shock: revisit the basics and consider giving it another chance.

Skirecki T, Kawiak J, Hoser G, Tarnowski W, Zlotorowicz M, Zielińska-Borkowska U.

Am J Respir Crit Care Med. 2013 Jan 15;187(2):217-9. No abstract available.

PMID:
23322799
32.

Myogenic potential of mesenchymal stem cells - the case of adhesive fraction of human umbilical cord blood cells.

Grabowska I, Streminska W, Janczyk-Ilach K, Machaj EK, Pojda Z, Hoser G, Kawiak J, Moraczewski J, Ciemerych MA, Brzoska E.

Curr Stem Cell Res Ther. 2013 Jan;8(1):82-90.

PMID:
23270632
33.

Cytotoxicity of bacterial metabolic products, including listeriolysin O, on leukocyte targets.

Stachowiak R, Lyzniak M, Budziszewska BK, Roeske K, Bielecki J, Hoser G, Kawiak J.

J Biomed Biotechnol. 2012;2012:954375. doi: 10.1155/2012/954375. Epub 2012 Oct 3.

34.

Absolute counts of peripheral blood leukocyte subpopulations in intraabdominal sepsis and pneumonia-derived sepsis: a pilot study.

Hoser GA, Skirecki T, Złotorowicz M, Zielińska-Borkowska U, Kawiak J.

Folia Histochem Cytobiol. 2012 Oct 9;50(3):420-6. doi: 10.5603/19751.

35.
36.

Restricted myogenic potential of mesenchymal stromal cells isolated from umbilical cord.

Grabowska I, Brzoska E, Gawrysiak A, Streminska W, Moraczewski J, Polanski Z, Hoser G, Kawiak J, Machaj EK, Pojda Z, Ciemerych MA.

Cell Transplant. 2012;21(8):1711-26. doi: 10.3727/096368912X640493. Epub 2012 Apr 17.

PMID:
22525423
37.

Rac2-MRC-cIII-generated ROS cause genomic instability in chronic myeloid leukemia stem cells and primitive progenitors.

Nieborowska-Skorska M, Kopinski PK, Ray R, Hoser G, Ngaba D, Flis S, Cramer K, Reddy MM, Koptyra M, Penserga T, Glodkowska-Mrowka E, Bolton E, Holyoake TL, Eaves CJ, Cerny-Reiterer S, Valent P, Hochhaus A, Hughes TP, van der Kuip H, Sattler M, Wiktor-Jedrzejczak W, Richardson C, Dorrance A, Stoklosa T, Williams DA, Skorski T.

Blood. 2012 May 3;119(18):4253-63. doi: 10.1182/blood-2011-10-385658. Epub 2012 Mar 12.

38.

Sepsis immunopathology: perspectives of monitoring and modulation of the immune disturbances.

Skirecki T, Borkowska-Zielińska U, Złotorowicz M, Hoser G.

Arch Immunol Ther Exp (Warsz). 2012 Apr;60(2):123-35. doi: 10.1007/s00005-012-0166-1. Review.

PMID:
22301668
39.

Different statins produce highly divergent changes in gene expression profiles of human hepatoma cells: a pilot study.

Leszczynska A, Gora M, Plochocka D, Hoser G, Szkopinska A, Koblowska M, Iwanicka-Nowicka R, Kotlinski M, Rawa K, Kiliszek M, Burzynska B.

Acta Biochim Pol. 2011;58(4):635-9. Epub 2011 Nov 30.

40.

Monoubiquitinated Fanconi anemia D2 (FANCD2-Ub) is required for BCR-ABL1 kinase-induced leukemogenesis.

Koptyra M, Stoklosa T, Hoser G, Glodkowska-Mrowka E, Seferynska I, Klejman A, Blasiak J, Skorski T.

Leukemia. 2011 Aug;25(8):1259-67. doi: 10.1038/leu.2011.91. Epub 2011 Apr 26.

41.

CD4+/CD25+ cells in systemic inflammation in COPD.

Domagała-Kulawik J, Hoser G, Dąbrowska M, Safianowska A, Chazan R.

Scand J Immunol. 2011 Jan;73(1):59-65. doi: 10.1111/j.1365-3083.2010.02474.x.

42.

Candidate bone-tissue-engineered product based on human-bone-derived cells and polyurethane scaffold.

Woźniak P, Bil M, Ryszkowska J, Wychowański P, Wróbel E, Ratajska A, Hoser G, Przybylski J, Kurzydłowski KJ, Lewandowska-Szumieł M.

Acta Biomater. 2010 Jul;6(7):2484-93. doi: 10.1016/j.actbio.2009.10.022. Epub 2009 Nov 4.

PMID:
19837193
43.

The experimental study of polyelectrolyte coatings suitability for encapsulation of cells.

Granicka LH, Antosiak-Iwańska M, Godlewska E, Hoser G, Strawski M, Szklarczyk M, Dudziński K.

Artif Cells Blood Substit Immobil Biotechnol. 2009;37(5):187-94. doi: 10.1080/10731190903199218.

PMID:
19757233
44.

Characterization of a new small cell lung cancer (SCLC) cell line STP54 derived from a metastatic bioptate of a combined type of SCLC with Non-SCLC component.

Skirecki T, Hoser G, Domagała-Kulawik J, Kawiak J.

Folia Histochem Cytobiol. 2009;47(1):111-5. doi: 10.2478/v10042-009-0018-y.

45.

SCID mice model in vivo evaluation of autologous and allogeneic dendritic cells activity on B-cell chronic lymphocytic leukemia.

Hus I, Kawiak J, Hoser G, Tabarkiewicz J, Radej S, Dmoszynska A, Rolinski J.

Folia Histochem Cytobiol. 2009;47(4):563-70. doi: 10.2478/v10042-008-0101-9.

46.

The ceramide structure of GM1 ganglioside differently affects its recovery in low-density membrane fractions prepared from HL-60 cells with or without triton-X100.

Panasiewicz M, Domek H, Hoser G, Fedoryszak N, Kawalec M, Pacuszka T.

Cell Mol Biol Lett. 2009;14(2):175-89. doi: 10.2478/s11658-008-0043-4. Epub 2008 Oct 31.

47.

Immunotherapy with irradiated autologous leukemic cells in patients with B-CLL in early stages.

Hus I, Kawiak J, Tabarkiewicz J, Radej S, Hoser G, Bojarska-Junak A, Schmitt M, Giannopoulos K, Dmoszynska A, Rolinski J.

Oncol Rep. 2008 Aug;20(2):443-51.

PMID:
18636210
48.

Increased proportion of Fas positive CD8+ cells in peripheral blood of patients with COPD.

Domagała-Kulawik J, Hoser G, Dabrowska M, Chazan R.

Respir Med. 2007 Jun;101(6):1338-43. Epub 2006 Nov 21.

49.

Effects of the phosphodiestrase-4 inhibitor rolipram on lung resistance and inflammatory reaction in experimental asthma.

Nejman-Gryz P, Grubek-Jaworska H, Glapiński J, Hoser G, Chazan R.

J Physiol Pharmacol. 2006 Sep;57 Suppl 4:229-39.

PMID:
17072051
50.

Structural insights into autoreactive determinants in thyroid peroxidase composed of discontinuous and multiple key contact amino acid residues contributing to epitopes recognized by patients' autoantibodies.

Dubska M, Banga JP, Plochocka D, Hoser G, Kemp EH, Sutton BJ, Gardas A, Gora M.

Endocrinology. 2006 Dec;147(12):5995-6003. Epub 2006 Sep 7.

PMID:
16959834

Supplemental Content

Support Center